Imaging Diagnosis of Various Hepatocellular Carcinoma Subtypes and Its Hypervascular Mimics: Differential Diagnosis Based on Conventional Interpretation and Artificial Intelligence.

Publication Year: 2022

DOI:
10.1159/000528538

PMCID:
PMC10267566

PMID:
37325493

Journal Information

Full Title: Liver Cancer

Abbreviation: Liver Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest Statement Prof. Kudo received grants from Gilead Sciences, Taiho, Sumitomo Dainippon Pharma, Takeda, Otsuka, EA Pharma, AbbVie, Eisai, Chugai, and GE Healthcare. He also received personal fees from Merck Sharpe and Dohme (MSD), Eli Lilly, Bayer, Eisai, Chugai, and Takeda. Prof. Nishida and Dr. Minami have no conflicts of interest to declare."

Evidence found in paper:

"No specific grant was received from any funding agency in the public, commercial, or not-for-profit sectors."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025